MedTrace Logo

Effect of 12-week Probiotic Supplementation on Bacterial and Viral Infections in Infants Aged 6 to 12 Months.

NCT01724203 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 192

Last updated 2013-10-11

No results posted yet for this study

Summary

The purpose of this clinical trial is to evaluate the safety and effectiveness of 12-week probiotic supplementation on the incidence and duration of infectious episodes in infants aged 6 to 12 months.

Conditions

  • Effect of Probiotics on Infections in Infants.

Interventions

DIETARY_SUPPLEMENT

Lactobacillus rhamnosus

DIETARY_SUPPLEMENT

Bifidobacterium animalis subsp. lactis

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    collaborator OTHER

  • Sprim Advanced Life Sciences

    collaborator OTHER

  • Fonterra Research Centre

    lead INDUSTRY

Principal Investigators

  • Xiaoyang Sheng, Dr · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
12 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01724203 on ClinicalTrials.gov